Skip to main content
. 2019 Feb 6;39(4):369–377. doi: 10.1007/s40261-019-00756-x

Fig. 2.

Fig. 2

Sub-analysis for symptom improvement rate at final visit in full analysis set population. LOX-O loxoprofen sodium oral, LOX-T loxoprofen sodium transdermal patch. p values were based on Pearson Chi-square test between two study groups